The global custom antibody market size was valued at USD 393.30 Million in 2024, driven by rising demand for personalised medicine across the globe. The market is expected to grow at a CAGR of 12.70% during the forecast period of 2025-2034, with the values likely to rise from USD 1.30 billion by 2034 .
The market growth is driven by the rising technical advancements in the antibody research domain. Numerous companies are expanding their biopharmaceutical division to develop efficient and better solutions for patients. In May 2023, Biosynth acquired United Kingdom based Cambridge Research Biochemicals, an independent producer and custom-made peptide and antibody tools. This acquisition is projected to benefit both United States and Europe population, as the companies aim at generating novel, or complex monoclonal as well as polyclonal antibodies that are not present in catalogs.
China based Biocytogen Pharmaceuticals Co. Ltd. revealed the expansion of their company into two new divisions in August 2023. These divisions are designed to focus on animal models and preclinical services along with development and discovery of new antibody-based drugs for out-licensing and partnerships. Such expansions will play a critical role in catering to the increasing demand for pharmaceuticals and will benefit the custom antibody market value significantly in upcoming years.
In Europe, antimicrobial resistance is a key area of attention amongst researchers. As a result, there is increased attention on adopting new technologies for effective antibody-based drugs. Having prominent research and academic institutions home is anticipated to contribute to contribute to the market growth significantly.
The Asia Pacific region is also poised to witness substantial custom antibody market value growth. Influential economies like India, Japan, Singapore, and China are continuously working towards improving the medical ecosystem. India is experiencing significant development with the launch of government initiatives like PRIP (Promotion of Research and Innovation in Pharma MedTech Sector) along with growing privatisation, which can be considered as a major driver for market growth in the forecast period.
This product will be delivered within 3-5 business days.
Custom Antibody: Introduction
Custom antibodies are specifically designed for research or diagnostic purposes. It involves generating antibodies that target specific antigens of interest through immunizing an animal, mostly, a rabbit or a mouse. They can be tailored for various applications like western blotting, ELISA, flow cytometry and other lab techniques. Custom antibodies play a crucial role when the usual antibodies do not meet the needs for a research project.Global Custom Antibody Market Analysis
The biopharmaceutical industry has seen significant growth in recent years. With focus on biologics, monoclonal antibodies, and personalized medicine to treat chronic diseases like cancer and autoimmune disorders, the custom antibody market demand has grown.The market growth is driven by the rising technical advancements in the antibody research domain. Numerous companies are expanding their biopharmaceutical division to develop efficient and better solutions for patients. In May 2023, Biosynth acquired United Kingdom based Cambridge Research Biochemicals, an independent producer and custom-made peptide and antibody tools. This acquisition is projected to benefit both United States and Europe population, as the companies aim at generating novel, or complex monoclonal as well as polyclonal antibodies that are not present in catalogs.
China based Biocytogen Pharmaceuticals Co. Ltd. revealed the expansion of their company into two new divisions in August 2023. These divisions are designed to focus on animal models and preclinical services along with development and discovery of new antibody-based drugs for out-licensing and partnerships. Such expansions will play a critical role in catering to the increasing demand for pharmaceuticals and will benefit the custom antibody market value significantly in upcoming years.
Global Custom Antibody Market Segmentation
Custom Antibody Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:Market Breakup by Product Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- Others
Market Breakup by Services
- Antibody Development
- Antibody Production and Purification
- Antibody Fragmentation and Labelling
- Others
Market Breakup by Source
- Mice
- Rabbit
- Others
Market Breakup by Application
- Oncology
- Infectious Diseases
- Neurology
- Stem cells
- Immunology
- Cardiovascular Diseases
- Others
Market Breakup by End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- CRO
- Hospitals and Clinics
- Others
Market Breakup by Distribution Channel
- Direct Tender
- Third Party Distributors
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Custom Antibody Market Overview
The United States has dominated the custom antibody market share globally. The market size can be accredited to a well-developed research infrastructure, along with the presence of influential pharmaceutical companies working seamlessly to develop more drugs and therapeutics. Moreover, the advent of artificial intelligence and digitally enabled tools is also helping to make the drug development processes rapid and precise.In Europe, antimicrobial resistance is a key area of attention amongst researchers. As a result, there is increased attention on adopting new technologies for effective antibody-based drugs. Having prominent research and academic institutions home is anticipated to contribute to contribute to the market growth significantly.
The Asia Pacific region is also poised to witness substantial custom antibody market value growth. Influential economies like India, Japan, Singapore, and China are continuously working towards improving the medical ecosystem. India is experiencing significant development with the launch of government initiatives like PRIP (Promotion of Research and Innovation in Pharma MedTech Sector) along with growing privatisation, which can be considered as a major driver for market growth in the forecast period.
Global Custom Antibody Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:- Thermo Fisher Scientific Inc.
- Creative Diagnostics
- Abcam plc.
- Bio-Rad Laboratories, Inc
- Kaneka Eurogentec S.A.
- YenZym Antibodies, LLC.
- Abmart
- Labcorp Drug Development
- LifeSpan BioSciences, Inc.
- GenScript
- Agilent Technologies
- Proteogenix
- Raybiotech, Inc.
- ProSci Incorporated
- Innovagen AB
This product will be delivered within 3-5 business days.
Table of Contents
1 Preface
3 Global Custom Antibody Market Overview
4 Global Custom Antibody Market Landscape
5 Global Custom Antibody Market Dynamics
6 Global Custom Antibody Market Segmentation
7 North America Custom Antibody Market
8 Europe Custom Antibody Market
9 Asia Pacific Custom Antibody Market
10 Latin America Custom Antibody Market
11 Middle East and Africa Custom Antibody Market
12 Patent Analysis
13 Grants Analysis
14 Funding Analysis
15 Partnership and Collaborations Analysis
16 Regulatory Framework
17 Supplier Landscape
18 Global Custom Antibody Market - Distribution Model (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
21 Payment Methods (Additional Insight)
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Creative Diagnostics
- Abcam plc.
- Bio-Rad Laboratories, Inc
- Kaneka Eurogentec S.A.
- YenZym Antibodies, LLC.
- Abmart
- Labcorp Drug Development
- LifeSpan BioSciences, Inc.
- GenScript
- Agilent Technologies
- Proteogenix
- Raybiotech, Inc.
- ProSci Incorporated
- Innovagen AB